Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Platelet Disorder Support Association (PDSA) is a premier non-profit patient advocacy organization dedicated to improving the lives of those with immune thrombocytopenia (ITP) and other platelet disorders. Founded in 1998, the association provides essential education, advocacy, and support services to patients, caregivers, and healthcare providers globally. PDSA actively funds research initiatives aimed at finding a cure and improving treatment outcomes for rare bleeding disorders. The organization also facilitates a network of support groups and hosts an annual ITP Conference to foster community and knowledge sharing. By collaborating with regulatory agencies and industry partners, PDSA ensures the patient perspective is integrated into the drug development process.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Platelet Disorder Support Association.